The newest formulation of the EMIT assay for drugs of abuse, EMIT II,
and a new immunoassay, OnLine, using the kinetic interaction of microp
articles in solution methodology, were evaluated for marijuana, cocain
e, opiates, barbiturates, and phencyclidine. Both types of immunoassay
s were performed on an Hitachi 717 analyzer. Calibration curves, the d
egree of separation between negative and cutoff calibrators, precision
, probability of carryover from positive to negative samples, and over
all ease and speed of analysis were evaluated. EMIT II and OnLine were
compared with RIA tests for the five drugs to determine each assay's
ability to detect samples which confirm positive by GC/MS. The RIA and
OnLine marijuana tests detected >99% of confirmed positive samples wh
ile EMIT II detected about 90%. All three immunoassays performed equiv
alently for cocaine and opiates, each assay detecting at least 98% of
positives. Barbiturates showed the greatest disparity with OnLine dete
cting 96%, EMIT II 85%, and RIA 79% of confirmed positive samples. Too
few phencyclidine positive samples were detected for a method compari
son study. The fully automated EMIT II and OnLine assays are preferabl
e for a variety of reasons to our laboratory's current semi-automated
RIA tests for large volume urine testing. The immunoassays offer compa
rable performance for some drugs but not for others.